Tamula, Richelle Mae S.
HRN: 24-79-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/10/2024
04/17/2024
IV
400 Mg
Q8
T/C Acute Surgical Abdomen
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes